1. Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
   Tutik Kusmiati et al, 2022, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases CrossRef
2. Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
   Elsje Pienaar et al, 2017, PLOS Computational Biology CrossRef
3. Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer
   Zongbin Xu et al, 2016, Experimental and Therapeutic Medicine CrossRef
4. Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
   Yuhui Xu et al, 2017, Annals of Clinical Microbiology and Antimicrobials CrossRef
5. MDR Tuberculosis Treatment
   Juan Espinosa-Pereiro et al, 2022, Medicina CrossRef
6. Immune formulation-assisted conventional therapy on anti-infective effectiveness of multidrug-resistant Mycobacterium tuberculosis infection mice
   Xiu-Li Yuan et al, 2016, Asian Pacific Journal of Tropical Medicine CrossRef